US$ 22.61
amylin glp-1 dual agonist Amycretin vs Semaglutide: Next-Gen GLP-1/Amylin vs Proven - Which Is Better? | PPW BioCentury - Could amylin outshine
Description
Computational methods have demonstrated their value in discovering new drugs and advancing their therapeutic development [27, 28]
What Made Semaglutide (Ozempic, Wegovy, Rybelsus) the Dominant Segment in the GLP-1 Drugs Market in 2025

Both companies are also investing in oral formulations, long-acting depot injections, and other delivery mechanisms that could transform how these peptides are administered

In particular, these conversations could help personalized treatment and help clinicians address patient fears related to thyroid cancer in general and the black box warning for MTC

All findings to date derive from preclinical and early investigational data

This episode was produced in collaboration with the American Society of Preventive Cardiology (ASPC) with independent medical education grant support from Novo Nordisk
